Sponsor or institution
Clinical trials and research at Tezcat Laboratories LLC
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $2.2 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
A new treatment for mutant Ras multiple myeloma using a specialized drug conjugate
This study is testing a new treatment for patients with a tough type of cancer called mutant Ras multiple myeloma, using a special drug that targets cancer cells to help improve their chances of recovery.
-
Monobody-delivered chemotherapy for KRAS-mutant pancreatic cancer
This project is developing TZT-102, a targeted drug that delivers a chemotherapy payload directly into KRAS-mutant pancreatic cancer cells.
-
A new treatment for mutant Ras multiple myeloma
This study is testing a new treatment for patients with a specific type of multiple myeloma that has a mutant Ras gene, using a special drug that aims to deliver powerful medicine directly to the cancer cells, and it could help those who haven't had success with other treatments.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.